College of medication researchers have been awarded funding from the Canadian Institutes of Well being Analysis by means of the Working Grant: COVID-19 Analysis Gaps and Priorities program.
The Honourable Patty Hajdu, Canada’s Minister of Well being, introduced an funding of roughly $25.2 million in 52 analysis tasks to additional enhance our understanding of COVID-19 and deal with persistent proof gaps linked to this illness.
Led by researchers throughout the nation, the brand new COVID-19 tasks will concentrate on subjects equivalent to variants of the virus, vaccine improvement and uptake, testing, psychological well being, and the methods wherein the COVID-19 pandemic is having particular impacts on ladies, racialized populations, and Métis, Inuit and First Nations Peoples.
“I congratulate the profitable analysis groups, whose work will handle probably the most urgent COVID-19 points dealing with Canadians and the world at present,” Minister Hajdu mentioned. “The brand new analysis will assist inform and speed up our efforts to enhance the well being of all populations. Investing in science is a prime precedence for our authorities in order that we will hold Canadians secure and wholesome throughout and following this pandemic.”
This funding will allow analysis groups to focus on precedence areas and advance our data and administration of COVID-19 associated points. The findings will serve to offer decision-makers with steerage to enhance the well being of our populations.
Six tasks led by UBC researchers have been awarded a complete of $1.9 million. Principal investigators for these tasks are primarily based at UBC and our affiliated well being authority analysis institutes.
College of medication awardees:
Peter Berman, College of Inhabitants and Public Well being
Challenge: Upstream determinants of efficient COVID-19 response: instruments improvement and software by means of a case research in British Columbia
CIHR funding: $118,575 (1 12 months)
Eric Jan, division of biochemistry and molecular biology
Challenge: Discovery of small molecules concentrating on SARS-CoV-2 frameshifting utilizing a fast yeast platform
CIHR funding: $445,230 (three years)
Sarka Lisonkova, division of obstetrics and gynecology
Challenge: All-cause and cause-specific acute morbidity attributable to Covid-19 epidemic, extreme Covid-19 signs, and antagonistic beginning outcomes in Canada.
CIHR funding: $168,300 (2 years)
Honglin Luo, division of pathology and laboratory medication
Challenge: Repurposing an FDA-approved anti-gout drug for the remedy of COVID-19
CIHR funding: $562,275 (three years)
Ian Pike, division of pediatrics
Challenge: The unintended penalties of implementing stay-at-home insurance policies throughout the COVID-19 pandemic: Violence outcomes in youngsters and youth in Canada
CIHR funding: $267,750 (three years)
Joseph Puyat and Rosemin Kassam, College of Inhabitants and Public Well being
Challenge: Brief and Lengthy Time period influence of COVID-19 on psychological well being and wellbeing of well being staff in Pakistan
CIHR funding: $302,175 (2.5 years)